Olympus Corporation has officially launched its next-generation EU-ME3 Ultrasound Processor in the U.S. market, following strong adoption in global regions. This advanced platform combines endoscopic (EUS) and endobronchial (EBUS) ultrasound functionalities into a single, compact system—offering a powerful, all-in-one solution for gastroenterology and pulmonology procedures. The launch aims to support U.S. healthcare providers with enhanced diagnostic capabilities for a broad range of conditions, including cancers of the digestive tract and lungs, where early and accurate detection is crucial for improving patient outcomes.

The EU-ME3 system stands out for its high-resolution imaging and smart technologies like s-FOCUS and Tissue Harmonic Echo, which improve clarity, reduce noise, and minimize artifacts. With backward and forward compatibility with Olympus’ EUS and EBUS endoscopes and miniature probes, the system promotes seamless integration into existing clinical workflows. It also enables tissue stiffness assessments through elastography and shear wave quantification, and offers contrast harmonic echo imaging to enhance lesion characterization. These features collectively empower physicians to conduct both diagnostic and interventional procedures with greater precision, confidence, and efficiency.